中文  |  ENGLISH

FACULTY

Position: HOME > PI



Yue Han, Ph.D.

 

199 Ren'ai Rd. Suzhou, Jiangsu 215123, P.R.China

Institute of Blood and Marrow Transplantation (IBMT), Soochow University

Phone:

Fax:

E-mail: hanyuesz@163.com

 

Education:

1987-1992, B.S., Medicine, Nanjing Medical University;

1996-1999, M.S., Hematology, Soochow University/ Jiangsu Institute of Hematology;

1999-2002, Ph.D., Hematology, Soochow University/ Jiangsu Institute of Hematology;

 

Professional Experience:

2006-2012, The First Afflicated Hospital of Soochow University, Hematology department, Associate Chief Physician, Associate Professor;

2012-present, The First Afflicated Hospital of Soochow University, Hematology department, Chief Physician, Professor;

 

Research:

1. Study of transplantation associated thrombotic microangiopathy pathogenesis and treatment;

2. Study on the treatment of refractory thrombocytopenia after hematopoietic stem cell transplantation;

3. Study on malignant hematologic disease and platelet.

 

Representative Publications

*corresponding author#co-first author)

1.Yue Han, Yaqiong Tang,Jia Chen, Jianying Liang, Chunmei Ye, Changgeng Ruan,  Depei Wu. Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Therapeutic Study. JAMA Oncol. 2015;1(2):249-252.

2.Zhao S, Zhang X, Xu Y, Feng Y, Sheng W, Cen J, Wu D, Han Y*. Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET).Int J Med Sci.2016, 25;13(1):85-91.

3.Tang Y, Wu Q, Wu X, Qiu H, Sun A, Ruan C, Wu D, Han Y*.Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia.Pak J Med Sci.2015;31(6):1389-1393. 

4. Zhu Q, Wang H, Ruan J, Guo L, Zhao S, Zhang W, Wang Q, Jin Z, Chen X, Sun A, Wu D, Han Y*. Analysis of prognostic factors for survival in 75 Chinese patients with peripheral T-cell lymphoma. Leukemia & Lymphoma, 2014;55(4):959-61

5.Han Y, Zhu L, Sun A, Lu X, Hu L, Zhou L, Ren Y, Hu X, Wu X, Wang Z, Ruan C, Wu D.Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem-cell transplantation related complications. Annal of Hematology, 2011,90(10): 1201-1208.

6.Han Y, Xiao J, Falls E, Zheng XL. A shear-based assay for assessing plasma ADAMTS13 activity and inhibitor in patients with thrombotic thrombocytopenic purpura. Transfusion, 2011, 51(7): 1580–1591.

7.Han Y, Wu D, Sun A, Xie Y, Xu J, Zhou J, Zhu X, Wang Z, Ruan C. Selective embolization of the internal iliac arteries for the treatment of severe hemorrhagic cystitis following hematopoietic SCT. Bone Marrow Transplant. 2008, 41(10):881-886.

8.Han Y, Nurden A, Combrié R, Pasquet JM. Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4.  J Thromb Haemost, 2003, 1(11):2206-2215.